STEPHANIE BAILEY: Open Payments
NPI 1477819274 · PLATTE CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 13 payments from 8 companies in 2025. Trend: 2023 $701 · 2024 $224 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $59 |
| Novo Nordisk Inc | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Dexcom, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Boston Scientific Corporation | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VRAYLAR, Wegovy, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, WATCHMAN FLX, Ozempic, Kerendia, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
